Aroa Biosurgery Limited
AROAF
$0.40
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.01M | -996.50K | -1.32M | -1.31M | -1.91M |
| Total Depreciation and Amortization | -- | -- | 690.90K | 681.40K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -481.50K | -476.50K | 2.66M | 2.63M | -301.00K |
| Change in Net Operating Assets | -- | -- | -2.05M | -2.03M | -- |
| Cash from Operations | -1.49M | -1.47M | -22.70K | -22.40K | -2.21M |
| Capital Expenditure | -478.40K | -473.40K | -432.40K | -426.50K | -638.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.87M | 2.84M | 2.95M | 2.91M | 1.22M |
| Cash from Investing | 2.39M | 2.36M | 2.51M | 2.48M | 585.90K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -246.00K | -246.00K | -177.50K | -177.50K | -192.50K |
| Issuance of Common Stock | 8.00K | 8.00K | 26.50K | 26.50K | 29.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -122.50K | -122.50K | -88.00K | -88.00K | -114.50K |
| Cash from Financing | -220.40K | -218.10K | -146.40K | -144.40K | -168.20K |
| Foreign Exchange rate Adjustments | -43.10K | -42.70K | -28.50K | -28.10K | 101.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 635.20K | 628.60K | 2.32M | 2.29M | -1.69M |
